Search Results
(±)10,11-EDT 100 µg | ≥98%
Cayman Chemical
(±)10,11-EDT 25 µg | ≥98%
Cayman Chemical
(±)10,11-EDT 50 µg | ≥98%
Cayman Chemical
(±)10,11-EDT 500 µg | ≥98%
Cayman Chemical
(±)10(11)-DiHDPA 1 mg | ≥98%
Cayman Chemical
(±)10(11)-DiHDPA 1 mg | Purity Not Available
TargetMol
(±)10(11)-DiHDPA is produced from cytochrome P450 epoxygenase action on docosahexaenoic acid . It has been shown to inhibit VEGF-induced angiogenesis in mice and may have additional anti-inflammatory and anti-tumor effects.
More Information Supplier Page(±)10(11)-DiHDPA 500 µg | ≥98%
Cayman Chemical
(±)10(11)-DiHDPA 100 µg | ≥98%
Cayman Chemical
(±)10(11)-DiHDPA 50 µg | ≥98%
Cayman Chemical
(±)10(11)-DiHDPA | MedChemExpress (MCE) 1 mg | ≥98.0%
MedChem Express
(±)10(11)-DiHDPA is a fatty acid diol and a metabolite of epoxidized fatty acids (EpFAs)[1].
More Information Supplier Page

